-
Signature
-
/s/ Richard Eskew, Attorney-in-Fact
-
Issuer symbol
-
N/A
-
Transactions as of
-
09 Jan 2024
-
Net transactions value
-
-$1,119,930
-
Form type
-
4
-
Filing time
-
11 Jan 2024, 18:14:11 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ACCD |
Common Stock |
Sale |
$543,152 |
-36,199 |
-4.9% |
$15.00 |
705,083 |
09 Jan 2024 |
Direct |
F2, F3 |
| transaction |
ACCD |
Common Stock |
Options Exercise |
$152,036 |
+36,199 |
+5.1% |
$4.20 |
741,282 |
09 Jan 2024 |
Direct |
F2 |
| transaction |
ACCD |
Common Stock |
Options Exercise |
$282,538 |
+67,271 |
+9.1% |
$4.20 |
808,553 |
10 Jan 2024 |
Direct |
F2 |
| transaction |
ACCD |
Common Stock |
Sale |
$1,011,352 |
-67,271 |
-8.3% |
$15.03 |
741,282 |
10 Jan 2024 |
Direct |
F2, F4 |
| holding |
ACCD |
Common Stock |
|
|
|
|
|
651,619 |
09 Jan 2024 |
By Avanti Holdings, LLC |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ACCD |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-36,199 |
-3.5% |
$0.000000 |
993,610 |
09 Jan 2024 |
Common Stock |
36,199 |
$4.20 |
Direct |
F5 |
| transaction |
ACCD |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-67,271 |
-6.8% |
$0.000000 |
926,339 |
10 Jan 2024 |
Common Stock |
67,271 |
$4.20 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: